< All M2M offers


Pepscan offers a range of patented technologies, phage display capabilities, a lead-optimization array platform, and production facilities for R&D- to GMP-grade peptides, including libraries and neoantigen vaccines. Among its patents is the CLIPS technology, which locks peptides into active conformations.

Pepscan also supports biotech companies in developing their antibody pipelines with its epitope mapping platform. The underlying protein mimicry platform delivers binding insights, even in cases where other technologies, such as linear, fall short.

About Pepscan
Pepscan is an all-in-one partner in peptides with about 40 employees and an end-to-end facility in Lelystad. Pepscan builds on 25 years of experience in advancing and applying peptide expertise to facilitate clients in the development and production of peptides. With its epitope mapping service, Pepscan supports biotech companies in determining the binding sites of their antibody. http://www.pepscan.com.


Zuidersluisweg 2
8243 RC Lelystad
The Netherlands

ContactpersoonEvert van Dijk – Chief Commercial Officer
Telefoon+31 320 225300
PromotiecodeOptioneel veld
ServicesCustom Peptide Synthesis, GMP Peptide Synthesis, Clinical Peptides (incl. Neoantigen Vaccines), Peptide Drug Discovery, Epitope Mapping